Gland Pharma Schedules Q2 FY27 Earnings Conference Call
Gland Pharma Ltd 路 Intimation 路 06 Nov 2026, 6:30 pm
Gland Pharma Schedules Q2 FY27 Earnings Conference Call Gland Pharma Limited will host an earnings conference call for investors and analysts on 6th Nov'26 at 18:30 IST for 60 minutes. The management team will discuss the company's financial performance and business updates for the quarter and half-year ended 30th Sep'26 (Q2 FY27). Universal dial-in access numbers include +91 22 6280 1516 and +91 22 7115 8875, alongside international toll-free options. The audio recording and transcript will subsequently be made available on the company鈥檚 official website.
Original exchange filing (PDF)
More announcements from Gland Pharma Ltd
- Schedule of Investor Meet Intimation 路 17 Nov 2026
- Allotment of 3739 Equity Shares on exercise of ESOPs 路 16 Nov 2026
- Grant of Options to Purchase Securities 路 16 Nov 2026
- Q2FY27 Earnings Call Transcript 路 12 Nov 2026
- Gland Pharma Limited has issued Corporate Guarantee on behalf of Phixen SAS, wholly owned step down subsidiary of the Company 路 12 Nov 2026
- Appointment of Mr. Xiao Le as Chief Investment Officer at Gland Pharma International Pte. Ltd, wholly owned subsidiary of Gland Pharma Limited, effective November 09, 2026 路 09 Nov 2026
- Q2FY27 Earnings Call Recording 路 07 Nov 2026
- Q2Fy27 Investors presentation 路 06 Nov 2026
